Latest Stories
Featured Stories
Explore inspiring journeys of recovery and resilience as patients share their experiences with Padaav’s root-cause-focused, evidence-based Ayurvedic treatments, highlighting the power of personalized care and holistic healing.
Feedback
All Stories
Delve into the heartfelt experiences of patients who have transformed their health and lives with Padaav’s research-backed Ayurvedic care, showcasing the impact of addressing root causes for lasting recovery.
Shalini Garg
IBS (Irritable Bowel Syndrome)
Delhi
This story is a powerful testament to resilience and hope. It narrates the journey of Shalini Gar…
Gaurav Kumar
Chronic Calcific Pancreatitis
Delhi
For over a decade, Gaurav Kumar was trapped in a relentless cycle of agony and hospitalization, b…
Avichal Dixit
Chronic Calcific Pancreatitis
Pilibhit, Uttar Pradesh
This narrative traces the rapid systemic degradation faced by Avichal Dixit, a talented young stu…
Ravinder Kumar
Recurrent Acute Pancreatitis, Diabetes
Panipat, Haryana
This story is a powerful testament to resilience and hope. It narrates the journey of Ravinder Ku…
Rohit Gupta
Chronic Pancreatitis
New Delhi
This is the story of Rohit Gupta , whose resilience transformed a seemingly insurmountable clinic…
Vivaan Guleria
Acute on Chronic Pancreatitis
Dharamshala, Himachal Pradesh
This story is a powerful testament to resilience and hope. It narrates the journey of Vivaan Gule…
Research
Our Research
At Padaav, alongside delivering unparalleled patient care and promoting holistic health, we are committed to advancing Ayurveda by actively participating in research and contributing to its growing body of knowledge.
Treatment of relapsed undifferentiated acute myeloid leukemia (AML-M0) with Ayurvedic therapy
A 16-year-old boy with AML-M0 relapsed after chemotherapy in 1997. He opted for Ayurvedic therapy (AYT) instead of further treatment. After six months, he was in remission and continued AYT for five years, with intermittent maintenance for two years. He has been disease-free and healthy for 12 years.
Changing Demography of Pancreatitis Patients in India -A Hospital Based Study
Pancreatitis is rising globally, with major risk factors including alcohol, tobacco, and family history. A study of 800 patients in North India found higher incidences among non-alcoholic, non-tobacco users, and those with no family history. The disease mostly affected men (4.6:1) aged 19-45, particularly in the service class and students. Further research is needed to explore its causes and extent in the region.
Case studies on prophylactic ayurvedic therapy in migraine patients
Ayurvedic treatment has shown effectiveness in managing migraines. A protocol (ATP) with herbo-mineral formulations, regular meals, and sleep reduced migraine frequency and intensity in a study of nine patients. Five reported significant improvement after 120 days, with no serious side effects. Ongoing research is further validating the findings.
Herbo-mineral ayurvedic treatment in a high risk acute promyelocytic leukemia patient with second relapse: 12 years follow up
A 47-year-old diabetic male with high-risk AML-M3 relapsed after multiple chemotherapy treatments. In 1997, he opted for a pilot Ayurvedic study and was treated with Navajeevan, Kamadudha Rasa, and Keharuba Pisti. He achieved complete remission and has remained disease-free for 13 years without side effects from the alternative treatment.
Prevalence of Anemia among Pregnant Women and Adolescent Girls in 16 Districts of India
Nutritional anemia is widespread in India, affecting 84.9% of pregnant women and 90.1% of adolescent girls. Severe anemia is prevalent in both groups. The Government of India provides iron and folic acid to pregnant women, but no similar program exists for adolescent girls. Interventions should address iron, B12, and folic acid deficiencies.
Sustainable Effect of Ayurvedic Formulations in the Treatment of Nutritional Anemia in Adolescent Students
This study evaluated the impact of Ayurvedic treatments (Sootshekhar Rasa and Sitopaladi Churna) on nutritional anemia in 1322 adolescent students in Dehradun. After 90 days of treatment, significant hemoglobin improvements were seen in the treatment groups, especially those receiving a daily dose of 250 mg SR and 400 mg SC. The study concluded that this combination effectively improves anemia in adolescents without adverse effects.